SCHEMBL15415906

SCHEMBL15415906

Clc1nc(Cl)c2nc(Br)cn2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31528248 0.81 ADORA1 (0.35)
SCHEMBL31038532 0.77 KDM4E (0.33)
SCHEMBL31625047 0.76
SCHEMBL24387224 0.76 ALDH1A1 (0.42)
SCHEMBL31305879 0.73 GAA (0.34)
SCHEMBL31038498 0.73 ROCK1 (0.34)
SCHEMBL31625294 0.72 KDM4E (0.30)
SCHEMBL1744654 0.68 MAPT (0.32)
SCHEMBL18414638 0.67 AHR (0.33)
SCHEMBL24386981 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114057744-B Process for preparing KRAS G12C inhibitors imidazotriazines and pyrrolopyrimidine derivatives 百济神州(北京)生物科技有限公司 2025-01-17 CN disclosed
CN-114057743-B Process for preparing KRAS G12C inhibitors imidazotriazines and pyrrolopyrimidine derivatives 百济神州(北京)生物科技有限公司 2025-01-07 CN disclosed
EP-2872514-A1 IMIDAZOTRIAZINECARBONITRILES USEFUL AS KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2015-05-20 EP disclosed
WO-2014011974-A1 IMIDAZOTRIAZINECARBONITRILES USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2014-01-16 WO disclosed